COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C, METHOTREXATE, CISPLATIN, AND VINBLASTINE IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER

被引：0
|
作者：
NIELL, HB
GRIFFIN, JP
WEST, WH
NEELY, CL
机构：
[1] UNIV TENNESSEE,CTR HLTH SCI,DEPT PHARMACOL,MEMPHIS,TN 38163
[2] VET ADM MED CTR,HEMATOL ONCOL SECT,MEMPHIS,TN 38104
[3] BAPTIST MEM HOSP,MED STAFF,MEMPHIS,TN 38146
来源：
CANCER | 1984年 / 54卷 / 07期
关键词：
D O I：
10.1002/1097-0142(19841001)54:7<1260::AID-CNCR2820540705>3.0.CO;2-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1260 / 1263
页数：4
相关论文
共 50 条
  • [41] COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C AND VINDESINE IN THE TREATMENT OF NON SMALL CELL LUNG-CARCINOMA (NSCLC)
    KLASTERSKY, J
    SCULIER, JP
    MOMMEN, P
    RAVEZ, P
    LIBERT, P
    VANDERMOTEN, G
    BECQUART, D
    SCHMERBER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 153 - 153
  • [42] A RANDOMIZED PROSPECTIVE-STUDY OF CISPLATIN AND VINBLASTINE VERSUS CISPLATIN, VINBLASTINE AND MITOMYCIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    MYLONAKIS, N
    TSAVARIS, N
    BACOYIANNIS, C
    KARVOUNIS, N
    KAKOLYRIS, S
    KARABELIS, A
    BEER, M
    KOSMIDIS, P
    ANNALS OF ONCOLOGY, 1992, 3 (02) : 127 - 130
  • [43] THE COMBINATION OF MITOMYCIN, VINBLASTINE AND CISPLATIN IS ACTIVE IN THE PALLIATION OF STAGE-IIIB-IV NON-SMALL-CELL LUNG-CANCER
    VINANTE, O
    BARI, M
    SEGATI, R
    AZZARELLO, G
    SAMPOGNARO, E
    ROSETTI, F
    PAPPAGALLO, GL
    ONCOLOGY, 1993, 50 (01) : 1 - 4
  • [44] IFOSFAMIDE, MITOMYCIN-C AND VINDESINE ADAPTED TO THE PERFORMANCE STATUS IN DISSEMINATED NON-SMALL CELL LUNG-CANCER
    RUGER, I
    SCHROEDER, M
    PUREA, H
    WESTERHAUSEN, M
    IFOSFAMIDE IN THE TREATMENT OF LUNG CANCER, 1989, 35 : 106 - 107
  • [45] CISPLATIN, VINBLASTINE AND BLEOMYCIN (PVB) FOR INOPERABLE NON-SMALL CELL LUNG-CANCER (NSCLC)
    STUARTHARRIS, R
    FOX, RM
    RAGHAVAN, D
    COATES, AS
    HEDLEY, D
    LEVI, JA
    WOODS, RL
    TATTERSALL, MHN
    MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (03): : 155 - 155
  • [46] Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancer
    Pujol, JL
    Quantin, X
    Choma, D
    Jacot, W
    Khial, F
    LUNG CANCER, 2002, 38 : S57 - S60
  • [47] CHEMOTHERAPEUTIC TREATMENT IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - A FURTHER ATTEMPT TO MODULATE CISPLATIN, VINBLASTINE AND MITOMYCIN-C (PVM) SCHEDULE
    TUMMARELLO, D
    ISIDORI, P
    GRAZIANO, F
    MARI, D
    CELLERINO, R
    ONCOLOGY REPORTS, 1994, 1 (02) : 415 - 418
  • [48] MITOMYCIN-C IFOSFAMIDE VS MITOMYCIN-C VINDESINE VS CISPLATINUM ETOPOSIDE IN ADVANCED NON-SMALL CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED TRIAL
    GATZEMEIER, U
    HECKMAYR, M
    HOSSFELD, DK
    KAUKEL, E
    KOSCHEL, G
    NEUHAUSS, R
    IFOSFAMIDE IN THE TREATMENT OF LUNG CANCER, 1989, 35 : 108 - 118
  • [49] MITOMYCIN-C, VINDESINE, AND CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    FUKUOKA, M
    NEGORO, S
    MASUDA, N
    KUSUNOKI, Y
    MATSUI, K
    RYU, S
    TAKIFUJI, N
    KUDOH, S
    TAKADA, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (01): : 18 - 22
  • [50] SYNERGIC EFFECT OF CISPLATIN, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE COMBINATION CHEMOTHERAPY AND RADIOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    YONEDA, S
    HONMA, T
    YOSHIDA, S
    MIN, KY
    NOGUCHI, Y
    SAKURA, M
    ONCOLOGY, 1985, 42 (01) : 1 - 6
12345